What is the recommended oral dose of furosemide (Lasix) for a neonate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Furosemide Dosing in Neonates

For neonates requiring oral furosemide, start with 0.5–2 mg/kg per dose, administered up to 6 times daily (maximum 10 mg/kg/day) for severe edema, or use 2–5 mg/kg per day divided for stable patients, with the critical caveat that doses exceeding 6 mg/kg/day should never be continued beyond 1 week due to irreversible ototoxicity risk. 1

Initial Dosing Strategy

For acute management of severe edema:

  • Begin with 0.5–2 mg/kg per dose orally, administered up to 6 times daily based on edema severity and diuretic response 1
  • The absolute maximum daily dose is 10 mg/kg/day, reserved only for extreme circumstances of severe fluid overload 1, 2
  • The FDA-approved pediatric dosing starts at 2 mg/kg as a single dose, which may be increased by 1–2 mg/kg increments no sooner than 6–8 hours after the previous dose 3

For stable/maintenance therapy:

  • Use 2–5 mg/kg per day orally, typically divided into 1–2 daily doses 1
  • Consider combination with a thiazide or potassium-sparing diuretic (preferably amiloride over spironolactone) for enhanced effect 1

Critical Safety Thresholds

The most important safety consideration is ototoxicity:

  • Never exceed 6 mg/kg/day for longer than 1 week to prevent permanent hearing loss 1, 2
  • High doses (>6 mg/kg/day) carry a 48-fold increased risk of nephrocalcinosis in low birth weight infants 4
  • Cumulative doses above 4 mg/kg significantly increase the risk of electrolyte abnormalities, particularly in preterm neonates 5

Mandatory Pre-Administration Assessment

Never administer furosemide if any of the following are present:

  • Marked hypovolemia or signs of intravascular volume depletion 1, 2
  • Hypotension or poor peripheral perfusion 1
  • Anuria (must stop furosemide immediately if this develops) 1
  • Severe hyponatremia 1

Before each dose, assess:

  • Intravascular volume status (capillary refill time, blood pressure, heart rate) 1, 2
  • Urine output and fluid balance 1, 2
  • Serum electrolytes (sodium, potassium, calcium, magnesium, bicarbonate, chloride) 1, 5
  • Renal function (serum creatinine, estimated GFR) 1

Essential Monitoring During Therapy

Continuous monitoring requirements include:

  • Fluid status and urine output (target varies by indication but generally >1 mL/kg/hour) 1, 4
  • Electrolytes: hypokalaemia and hyponatraemia are common complications requiring replacement 1, 5
  • Blood pressure: watch for hypotension from excessive diuresis 1
  • Body weight: daily weights help assess fluid balance 5
  • Renal function: elevated serum creatinine occurred in 21% of critically ill neonates receiving furosemide 5

Special Clinical Contexts

For congenital nephrotic syndrome:

  • The 2021 ERKNet-ESPN consensus guidelines specifically address this population 1
  • Use furosemide cautiously and only with intravascular fluid overload (good perfusion + high blood pressure) 1
  • Consider 0.5–2 mg/kg IV or oral bolus at the end of albumin infusions if no marked hypovolemia present 1

For congestive heart failure:

  • Start at 1 mg/kg and titrate by 1 mg/kg increments until adequate diuresis 6
  • Frequency up to 6 times daily based on edema and diuresis 6
  • Use cautiously in dilated cardiomyopathy as acute preload reduction may cause hypotension 6

For premature infants:

  • Maximum dose should not exceed 1 mg/kg/day due to increased vulnerability 7
  • Half-life is considerably longer (8–27 hours) compared to adults (33–100 minutes), necessitating less frequent dosing 4
  • Clearance is significantly reduced at birth and improves with maturation 4

Route Considerations: Oral vs. IV

Oral bioavailability considerations:

  • Oral absorption is variable in neonates, particularly in critically ill patients 4, 8
  • The Nature Reviews Nephrology guidelines note that oral and IV routes can be used interchangeably at the same mg/kg dose for severe edema management 1
  • For acute situations requiring rapid diuresis, IV route is preferred; oral route is appropriate for stable maintenance therapy 1

Common Pitfalls to Avoid

  1. Do not use furosemide routinely or prophylactically (e.g., for blood transfusions)—reserve only for symptomatic fluid overload 7

  2. Never exceed 6 mg/kg/day for more than 1 week without compelling indication, as permanent hearing loss can occur 1, 2, 7

  3. Avoid administering in hypovolemic states—furosemide worsens volume depletion and can precipitate thrombosis 1, 2

  4. Do not combine with indomethacin without careful monitoring, as this increases acute renal failure risk 4

  5. Monitor for nephrocalcinosis in low birth weight infants receiving cumulative doses >10 mg/kg 4

  6. Ensure adequate electrolyte replacement, particularly potassium, as hypokalemia is common 1, 5

Practical Dosing Algorithm

Step 1: Assess volume status

  • If hypovolemic, hypotensive, or anuric → DO NOT give furosemide 1, 2
  • If euvolemic with fluid overload → proceed to Step 2

Step 2: Determine severity

  • Severe edema: Start 0.5–2 mg/kg per dose orally, up to 6 times daily (max 10 mg/kg/day) 1
  • Moderate/stable: Start 2–5 mg/kg/day orally divided 1–2 times daily 1

Step 3: Titrate based on response

  • Increase by 1–2 mg/kg increments if inadequate diuresis after 6–8 hours 3
  • Never exceed 6 mg/kg/day for >1 week 1, 2

Step 4: Monitor and adjust

  • Check electrolytes, renal function, and fluid status before each dose adjustment 1, 5
  • Consider adding thiazide or amiloride if response inadequate at maximum safe furosemide dose 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Furosemide Dosing Guidelines for Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Furosemide Dosing for Pediatric Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Furosemide Dosing for Pediatric Blood Transfusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacology of furosemide in children: a supplement.

American journal of therapeutics, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.